Catalyst Wire Dossier Catalyst Wire Dossier

Lorexys

· S1 Biopharma, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Lorexys, covering 2014-10-28 to 2014-10-28. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1b/2a Unblinded Study of Responses in Premenopausal Women With HSDD to Lorexys Evaluating Efficacy and Safety [Phase 1, Phase 2]

See pricing